Purpose | Dosage Range | Frequency | Administration |
---|---|---|---|
General Anti-Aging | 5-10 mg | Once daily for 10-20 days | Subcutaneous injection |
Sleep Improvement | 5-10 mg | Once daily before bed | Subcutaneous injection |
Immune Enhancement | 10 mg | Once daily for 10 days | Subcutaneous injection |
Research | 0.1-10 mg/kg | As per protocol | Subcutaneous/Intraperitoneal |
2. What is Epithalon?
Chemical formula: C14H22N4O5
Molecular weight: 390.35 g/mol
Sequence: Ala-Glu-Asp-Gly
Developed by Vladimir Khavinson in the 1980s
Derived from Epithalamin, a polypeptide extract from bovine pineal gland
Known for its potential anti-aging and telomere-lengthening properties
Stimulates the production of telomerase, an enzyme that extends telomeres
Regulates melatonin production in the pineal gland
Modulates neuroendocrine functions
Enhances antioxidant activity
Influences gene expression related to cell cycle and apoptosis
Regulates circadian rhythms
Potentially affects the immune system function
Potential to extend lifespan by preserving telomere length
May slow down cellular aging processes
Improves melatonin production
Enhances sleep quality and regulates circadian rhythms
Potential to boost immune system activity
May enhance resistance to infections
Possible neuroprotective effects
May improve memory and cognitive performance in aging individuals
Potential to improve heart health markers
May reduce risk of age-related cardiovascular diseases
Epithalon and Cancer
Possible anti-tumor effects
May enhance the efficacy of some cancer treatments
Potential to improve retinal function
May help in treating or preventing age-related eye disorders
Typical dose: 5-10 mg per day
Administered once daily for 10-20 days
Cycles repeated 2-4 times per year
Dose: 5-10 mg per day
Administered once daily before bedtime
Dose: 10 mg per day
Administered once daily for 10 days
Dose range: 0.1-10 mg per kg of body weight
Frequency depends on research protocol
Reconstitute lyophilized Epithalon with bacteriostatic water
Use sterile injection materials
Calculate dosage based on body weight or research protocol
Draw correct amount into insulin syringe
Administer via subcutaneous injection
Most common method for research and general use
Inject into fatty tissue of abdomen or thigh
Used in some animal studies
Not typically used in human applications
May enhance sleep-regulating effects
Potential synergistic effects on cellular health
Dose: 10 mg per day
Administered once daily for 10 days
Injection site reactions
Headache
Dizziness
Fatigue
Not approved by the FDA for human use
Legal status varies by country and jurisdiction
Often restricted to research or medical use
In the US, it's legal to possess for research purposes but not for human consumption
Store lyophilized powder at -20°C (-4°F)
Once reconstituted, store in refrigerator (2-8°C or 36-46°F)
Use within 30 days after reconstitution
Protect from light and excessive heat
Always use sterile techniques when handling
Effects may vary, but some users report improvements in sleep and energy within 1-2 weeks. Long-term effects on aging may take months to years to become apparent.
Yes, Epithalon is primarily studied for its potential anti-aging effects, particularly its ability to potentially extend telomere length.
Dose: 10 mg per day
Administered once daily for 10 days
Epithalon is unique in its ability to potentially stimulate telomerase production. It may have synergistic effects when combined with other anti-aging interventions.
Long-term safety data is limited. Potential risks include disruption of natural hormone production and possible effects on cell division. More research is needed to fully understand long-term effects.
Epithalon shows promise as a potential anti-aging peptide with a range of possible benefits, including telomere preservation, improved sleep quality, and enhanced immune function. The typical dosage range of 5-10 mg administered once daily for 10-20 days, repeated 2-4 times per year, appears to be the most commonly used protocol in research settings.However, its use should be approached cautiously due to limited long-term human safety data and varying legal status worldwide. As with any experimental compound, thorough research and professional consultation are essential before use. The potential of Epithalon in longevity and age-related conditions warrants further investigation, particularly in larger, long-term human trials.
Khavinson VK, et al. (2003). Peptide promotes overcoming of the division limit in human somatic cell. Bulletin of Experimental Biology and Medicine, 135(6), 590-592.
Anisimov VN, et al. (2003). Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology, 4(4), 193-202.
Korkushko OV, et al. (2004). Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging. Bulletin of Experimental Biology and Medicine, 138(5), 441-443.
Khavinson V, et al. (2009). Peptides and ageing. Neuroendocrinology Letters, 30(3), 343-355.
Khavinson VK, Morozov VG. (2003). Peptides of pineal gland and thymus prolong human life. Neuroendocrinology Letters, 24(3-4), 233-240.
Disclaimer
Peptideresearcher.com contains information about products intended for research and laboratory use only, unless otherwise explicitly stated. All content is for educational purposes and is not meant to substitute for professional medical advice. Peptideresearcher.com strives to ensure that all information presented is accurate and complies with national and international standards, but it is not guaranteed. The content provided is not intended to diagnose, treat, cure, or prevent any disease or condition.
Peptideresearcher.com does not offer medical diagnoses or prescriptions. Any product information shared is solely for research purposes and should be used by qualified professionals only. We advise all users to consult with a healthcare professional before using any peptides, supplements, or medications mentioned on this site. All opinions expressed are those of the individual authors and may not reflect the opinions of Peptideresearcher.com.
Copyright 2024 - Peptide Researcher
Your access to Peptideresearcher.com is subject to our Terms of Use